Double maintains 2 strategies that include NVS - Novartis AG
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
GSK | 49.02% | $80.20B | -6.99% | 3.96% |
AWK | 48.01% | $27.65B | +19.96% | 2.15% |
AZN | 46.97% | $237.31B | +15.61% | 2.05% |
KO | 45.55% | $300.00B | +15.28% | 2.83% |
UL | 44.42% | $148.84B | +19.75% | 3.19% |
O | 43.94% | $50.33B | +7.56% | 5.61% |
ED | 43.75% | $38.30B | +22.37% | 3.09% |
ABT | 43.02% | $219.88B | +13.69% | 1.77% |
GIS | 42.99% | $32.14B | -15.20% | 4.10% |
WTRG | 42.53% | $10.68B | +6.35% | 3.30% |
SJW | 41.95% | $1.76B | -7.90% | 3.12% |
CMS | 41.86% | $22.02B | +25.13% | 2.83% |
MSEX | 41.71% | $1.06B | +15.84% | 2.24% |
POR | 41.21% | $4.85B | +8.44% | 4.48% |
MDLZ | 41.07% | $82.72B | -11.44% | 2.80% |
WEC | 40.84% | $34.05B | +34.70% | 3.15% |
ES | 40.82% | $22.61B | +6.41% | 4.72% |
PSA | 40.20% | $52.01B | +5.19% | 4.06% |
FCPT | 39.98% | $2.85B | +16.31% | 4.91% |
SO | 39.94% | $98.68B | +28.71% | 3.21% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BIRK | -0.01% | $8.48B | -3.40% | 0.00% |
BURL | 0.03% | $15.02B | +4.07% | 0.00% |
FLS | -0.03% | $6.78B | +11.93% | 1.65% |
PRMB | -0.03% | $12.32B | +83.76% | 1.15% |
ENTG | -0.04% | $14.99B | -29.56% | 0.41% |
RDNT | 0.04% | $3.68B | +5.38% | 0.00% |
CCJ | -0.04% | $19.52B | +5.18% | 0.26% |
ETON | 0.06% | $393.66M | +308.29% | 0.00% |
BVS | -0.06% | $644.37M | +79.37% | 0.00% |
SUP | 0.06% | $71.97M | -13.54% | 0.00% |
ASTS | 0.07% | $5.61B | +788.13% | 0.00% |
TWLO | 0.07% | $15.54B | +65.40% | 0.00% |
BE | -0.08% | $5.85B | +158.76% | 0.00% |
ASML | -0.08% | $288.69B | -25.91% | 0.94% |
HIMS | 0.09% | $7.30B | +96.47% | 0.00% |
TBCH | 0.09% | $285.13M | -18.67% | 0.00% |
GPCR | 0.09% | $1.25B | -50.16% | 0.00% |
TBI | -0.09% | $172.31M | -52.88% | 0.00% |
SSYS | -0.10% | $750.85M | -11.80% | 0.00% |
ZH | 0.10% | $371.20M | +1.62% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
USDU | -25.36% | $214.47M | 0.5% |
EQLS | -23.38% | $6.31M | 1% |
UUP | -23.31% | $332.64M | 0.77% |
CTA | -15.49% | $927.03M | 0.76% |
VIXY | -14.81% | $195.31M | 0.85% |
TESL | -14.37% | $13.25M | 1.2% |
MAGS | -14.37% | $1.66B | 0.29% |
UNG | -13.00% | $456.14M | 1.06% |
CLSE | -11.82% | $171.66M | 1.55% |
FBCG | -10.74% | $3.68B | 0.59% |
FFOG | -10.74% | $111.70M | 0.55% |
YMAG | -10.65% | $306.03M | 1.12% |
FDN | -9.73% | $6.46B | 0.51% |
FBY | -9.48% | $156.28M | 1.06% |
DBE | -9.34% | $54.72M | 0.77% |
IGM | -9.29% | $5.41B | 0.41% |
IYW | -9.08% | $18.31B | 0.39% |
EETH | -8.80% | $46.52M | 0.95% |
QGRW | -8.28% | $849.61M | 0.28% |
IGPT | -8.15% | $405.11M | 0.58% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MRVL | -18.98% | $61.05B | +5.86% | 0.35% |
NVDA | -17.36% | $2.89T | +29.63% | 0.03% |
VRT | -17.07% | $33.92B | +8.49% | 0.14% |
ALAB | -17.06% | $11.18B | +7.51% | 0.00% |
GEV | -16.44% | $92.93B | +156.63% | 0.00% |
CRWD | -16.18% | $91.47B | +12.01% | 0.00% |
CEG | -15.63% | $68.65B | +26.02% | 0.67% |
GOOGL | -15.40% | $1.98T | +10.30% | 0.50% |
EME | -14.91% | $18.17B | +15.50% | 0.25% |
CAMT | -14.74% | $3.08B | -18.55% | 0.00% |
COHR | -14.48% | $10.65B | +8.65% | 0.00% |
GOOG | -14.37% | $2.01T | +10.97% | 0.49% |
PSTG | -14.37% | $16.57B | -3.88% | 0.00% |
NVT | -14.29% | $9.38B | -22.80% | 1.37% |
MYRG | -14.21% | $2.02B | -26.16% | 0.00% |
STRL | -14.21% | $3.85B | +14.53% | 0.00% |
CDNS | -14.09% | $70.86B | -19.92% | 0.00% |
AVGO | -13.83% | $895.91B | +41.35% | 6.48% |
PWR | -13.67% | $40.18B | +5.77% | 0.14% |
AMZN | -13.62% | $2.07T | +9.43% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SGOV | -0.07% | $38.60B | 0.09% |
BCI | -0.11% | $1.35B | 0.26% |
ULST | -0.22% | $584.04M | 0.2% |
CIBR | -0.24% | $8.11B | 0.59% |
XLC | 0.29% | $20.65B | 0.09% |
NUKZ | -0.36% | $207.28M | 0.85% |
ARKQ | 0.37% | $857.76M | 0.75% |
KBA | -0.38% | $182.55M | 0.56% |
ARKK | -0.43% | $5.43B | 0.75% |
URNJ | 0.46% | $218.34M | 0.8% |
FTQI | -0.50% | $579.72M | 0.75% |
SOCL | 0.60% | $121.43M | 0.65% |
PHDG | 0.62% | $115.22M | 0.39% |
COM | 0.65% | $244.68M | 0.72% |
HACK | -0.69% | $2.03B | 0.6% |
TAIL | 0.72% | $83.83M | 0.59% |
PDP | -0.77% | $1.23B | 0.62% |
QMOM | -0.87% | $299.70M | 0.29% |
CLOI | 0.91% | $997.25M | 0.4% |
QGRO | -0.93% | $1.16B | 0.29% |
Current Value
$113.031 Year Return
Current Value
$113.031 Year Return
SeekingAlpha
Merck and Bristol-Myers Squibb are key players in cancer treatment. Find out why MRK and BMY stocks have different prospects for long-term investment.
SeekingAlpha
Harrow, Inc. stock dropped 50% post-3Q24, but Q4 previews and FY2025 projections signal growth potential. Click for my updated look at HROW stock prospects.
SeekingAlpha
The fund posted returns of -6.71% (Institutional shares) and -6.78% (Investor A shares, without sales charge) for the fourth quarter of 2024. Read more here.
SeekingAlpha
In mid-Feb., Organon pleasantly surprised me with its financial results for Q4 2024. Read why I believe OGN is an attractive stock for income-oriented investors.
SeekingAlpha
Carvykti's success boosts Legend Biotech Corporation's Q4 2024 sales to $334M, solidifying market position. Click for my updated look at LEGN earnings.
SeekingAlpha
My strategy focuses on companies with consistent dividend growth and outperforming benchmarks. Check out this week's dividend increases.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
EWL | 63.16% | $1.19B | 0.5% |
PPH | 60.21% | $632.62M | 0.36% |
IXJ | 58.02% | $4.02B | 0.41% |
KXI | 52.71% | $704.97M | 0.41% |
EFAV | 51.94% | $4.75B | 0.2% |
ACWV | 51.10% | $3.38B | 0.2% |
XLV | 49.80% | $38.85B | 0.09% |
HDEF | 49.65% | $1.86B | 0.09% |
DWX | 49.52% | $410.74M | 0.45% |
GCOW | 49.16% | $2.19B | 0.6% |
IYH | 49.06% | $3.23B | 0.39% |
NFRA | 48.88% | $2.43B | 0.47% |
LVHD | 48.45% | $539.62M | 0.27% |
SPHD | 48.40% | $3.53B | 0.3% |
VHT | 47.54% | $16.69B | 0.09% |
FHLC | 47.45% | $2.75B | 0.084% |
SDY | 47.37% | $20.19B | 0.35% |
HDV | 47.10% | $11.20B | 0.08% |
FVD | 46.98% | $9.22B | 0.6% |
IYK | 46.91% | $1.43B | 0.4% |